Mizuho Securities Raises Price Target on Lab Corp. (LH) to $145; Reiterates Neutral

September 15, 2016 6:52 AM EDT
Get Alerts LH Hot Sheet
Price: $138.76 -0.76%

Rating Summary:
    17 Buy, 15 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade LH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities reiterated a Neutral rating on Laboratory Corporation of America (NYSE: LH), and raised the price target to $145.00 (from $132.00), after updating estimates. Estimates now include the recent close of the Sequenom acquisition. Mizuho believes that the acquisition could be $0.03 dilutive to adjusted EPS in 2016, but up to $0.04 accretive in 2017.

Analyst Ann Hynes commented, "We are increasing our price target (to $145 from $132), raising our LH adjusted EPS for 2016E (+$0.05) and 2017E (+$0.08), and introducing our 2018E adjusted EPS ($10.32) Our adjusted EPS now includes the recent acquisition of Sequenom. In general, we remain positive on LH operating trends, upside potential from Covance and solid cash flow trends. However, valuation keeps us on the sidelines at this juncture."

For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $132.99 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Definitive Agreement

Add Your Comment